ITGA2B and myocardial infarction: There is currently paucity of large-scale studies comparing the clinical antiplatelet effect and safety of GPIIb/IIIa antagonists as well as studies investigating the effect of GPIIb/IIIa antagonists on the prognosis of myocardial infarction.